Brepocitinib, a potent and selective TYK2/JAK1 inhibitor: scientific and clinical rationale for dermatomyositis

Zhang H, Patrick MT, Sarkar MK, Bogle R, Li Q, Uppala R, Perez White BE, Petukhova L, Dand N, Stuart PE, Christiano AM, Simpson MA,[...]

Mukadi PK, Merritt S, Nkuba-Ndaye A, Halbrook M, Anta Y, Bodisa Matamu T, Hasivirwe Vakaniaki E, Mukadi-Bamuleka D, Harrigan RJ, Lunyanga L, Kacita C, Kompany[...]

Yao Z, Alvarez PA, Chavez C, Delgado Y, Kaushal P, Buchholz DW, Austin D, Li Q, Yu Y, Zaiss AK, Arumugaswami V, Ding Q, Hsu[...]